Premarket Breakfast for Monday, July 22nd

Gm traders.

This week is earnings Super Bowl.
Earnings Calendar for the week of July 22nd
Gap Percent Ticker Company Name Industry Company Size Market Cap Description Tags Insights
112.2% SKIS Peak Resorts, Inc. ski resorts micro cap 77.3 Million
Co being acquired for $11/share in cash by Vail Reports $MTN.
71.9% TRNX Taronis Technologies, Inc. renewable energy nano cap 9.69 Million
[Penny stock] Issues a PR saying it executes a $165mm contract. show more
28.8% DRRX DURECT Corporation biotech (sustained release drugs) micro cap 129 Million
Co announces deal where they will out-license Gilead $GILD where they will allow Gilead exclusive use of their SABER technology for HIV and HBV to develop a HIV drug. show more
licensing agreement
8.0% BTAI BioXcel Therapeutics, Inc. biotech (psychiatric) micro cap 162 Million
Co announces drug results for its Phase 1b for BXCL501 for treatment of agitation in 135 patients with schizophrenia. show more
drug results
6.8% AMRX Amneal Pharmaceuticals, Inc. biotech (generics) small cap 1.01 Billion
Co gets upgraded to Outperform at SVB Leerink. show more
6.2% DVA DaVita Inc. dialysis clinics mid cap 9.44 Billion
Raises guidance, Co to conduct modified Dutch auction tender offer. show more
raised guidance
3.6% SFIX Stitch Fix, Inc. online retailer (clothes) mid cap 2.75 Billion
Co gets upgraded to buy at Stifel with price target of $35.  show more
3.3% MU Micron Technology, Inc. semiconductors large cap 50.3 Billion
Goldman Sachs upgrades Co to Buy, price target $56 from $40.  show more
2.1% DDS Dillard's, Inc. retail (clothes) small cap 1.65 Billion
[Yesterday] Huge squeeze yesterday, no news that I can find.  show more
short squeeze
1.7% BG Bunge Limited farm products mid cap 7.9 Billion
Co announces joint venture with BP $BP.  show more
joint venture
--% PACB Pacific Biosciences of California, Inc. biotech (genetic sequencing) small cap 898 Million
[Yesterday] Stock fell 14% on concerns that its buyout from Illumina $ILMN may not go through due to anti-competitive concerns from the British government.  show more
government action
--% SYMC Symantec Corporation cybersecurity large cap 14.2 Billion
[Yesterday] Stock fell 3% after the Co was added to a list of attendees for the Citi Global Technology conference in September.  show more
merger rumor
buyout rumor
--% MTN Vail Resorts, Inc. ski resorts mid cap 9.19 Billion
Co buying Peak Resorts $SKIS at $11/share cash. show more
--% BBIO BridgeBio Pharma, Inc. biotech (genetic diseases) mid cap 3.21 Billion
Sell side initiation today on the stock after its recent IPO.  show more
--% SLRX Salarius Pharmaceuticals biotech (cancer) --
Co competes merger with Flex Pharma, is now listed as $SLRX (previously $FLKS)
close merger
-2.8% MRKR Marker Therapeutics, Inc. biotech (cancer) micro cap 396 Million
Stock continues to fall after releasing interim data for its MultiTAA cell therapy for patients with pancreatic adenocarcinoma. show more
drug results
-3.5% CALM Cal-Maine Foods, Inc. egg producer small cap 1.9 Billion
Earnings, Co misses on EPS and revs, also not paying dividend for 4th quarter. show more
no dividend
earnings miss
-4.5% PAYS PaySign, Inc. prepaid cards and processing small cap 848 Million
Co got downgraded to sell at BTIG after the stock's 400% rally year-to-date.  show more
-4.5% PETS PetMed Express, Inc. online pet pharmacy micro cap 328 Million
Earnings, missed on EPS and revs.  show more
earnings miss
-5.7% LII Lennox International Inc. HVAC large cap 11.1 Billion
Earnings, these look pretty bad, EPS miss, revenue miss and lowers FY19 guidance. show more
earnings miss
-5.9% BHVN Biohaven Pharmaceutical Holding Company Ltd. biotech (neurodegenerative diseases) mid cap 2.32 Billion
Co receives FDA complete response letter (CRL) for its drug NURTEC for ALS.  show more
fda rejection
-23.2% CUR Neuralstem, Inc. biotech (cell production) nano cap 8.5 Million
Co files for equity offering for 1.3M units.
-74.9% NTEC Intec Pharma Ltd. biotech (neurodegenerative diseases) micro cap 100 Million
Co reported drug results for its Phase 3 study in patients with advanced Parkinson's, it was a fail. show more
Make sure you check out the Daily Episode

Behind The Bid has everything you need for your Premarket.
Visit daily for actionable, individual stock news at a glance.
Try our daily Premarket watchlist and daily Premarket YouTube show on at 8:20am ET.

© 2019 Behind The Bid, LLC